Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.28
BRKR's Cash to Debt is ranked lower than
53% of the 2544 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 4.42 vs. BRKR: 1.28 )
BRKR' s 10-Year Cash to Debt Range
Min: 0.13   Max: No Debt
Current: 1.28

Equity to Asset 0.43
BRKR's Equity to Asset is ranked lower than
56% of the 2511 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.57 vs. BRKR: 0.43 )
BRKR' s 10-Year Equity to Asset Range
Min: 0.14   Max: 0.69
Current: 0.43

0.14
0.69
Interest Coverage 11.06
BRKR's Interest Coverage is ranked lower than
55% of the 1460 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 97.77 vs. BRKR: 11.06 )
BRKR' s 10-Year Interest Coverage Range
Min: 0.71   Max: 9999.99
Current: 11.06

0.71
9999.99
F-Score: 7
Z-Score: 3.62
M-Score: -2.59
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 8.06
BRKR's Operating margin (%) is ranked higher than
79% of the 2407 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.72 vs. BRKR: 8.06 )
BRKR' s 10-Year Operating margin (%) Range
Min: -3.71   Max: 13.34
Current: 8.06

-3.71
13.34
Net-margin (%) 4.35
BRKR's Net-margin (%) is ranked higher than
69% of the 2409 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.07 vs. BRKR: 4.35 )
BRKR' s 10-Year Net-margin (%) Range
Min: -6.73   Max: 9.58
Current: 4.35

-6.73
9.58
ROE (%) 9.47
BRKR's ROE (%) is ranked higher than
76% of the 2378 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 5.68 vs. BRKR: 9.47 )
BRKR' s 10-Year ROE (%) Range
Min: -8.67   Max: 20.81
Current: 9.47

-8.67
20.81
ROA (%) 4.03
BRKR's ROA (%) is ranked higher than
69% of the 2414 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.88 vs. BRKR: 4.03 )
BRKR' s 10-Year ROA (%) Range
Min: -5   Max: 7.55
Current: 4.03

-5
7.55
ROC (Joel Greenblatt) (%) 22.98
BRKR's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 2406 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 11.68 vs. BRKR: 22.98 )
BRKR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5.86   Max: 37.1
Current: 22.98

-5.86
37.1
Revenue Growth (%) 11.50
BRKR's Revenue Growth (%) is ranked higher than
84% of the 1829 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.60 vs. BRKR: 11.50 )
BRKR' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 22.8
Current: 11.5

0
22.8
EBITDA Growth (%) 0.60
BRKR's EBITDA Growth (%) is ranked higher than
65% of the 1486 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.90 vs. BRKR: 0.60 )
BRKR' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 153.7
Current: 0.6

0
153.7
EPS Growth (%) -6.10
BRKR's EPS Growth (%) is ranked higher than
61% of the 1337 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.40 vs. BRKR: -6.10 )
BRKR' s 10-Year EPS Growth (%) Range
Min: 0   Max: 57.4
Current: -6.1

0
57.4
» BRKR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

BRKR Guru Trades in Q2 2013

Jim Simons 633,110 sh (New)
Pioneer Investments 137,200 sh (New)
Vanguard Health Care Fund 3,285,758 sh (+307.28%)
Joel Greenblatt 33,522 sh (+0.42%)
Paul Tudor Jones Sold Out
RS Investment Management Sold Out
Steven Cohen 36,437 sh (-55.84%)
» More
Q3 2013

BRKR Guru Trades in Q3 2013

Murray Stahl 16,530 sh (New)
NWQ Managers 220,478 sh (New)
Paul Tudor Jones 12,200 sh (New)
Steven Cohen 59,737 sh (+63.95%)
Vanguard Health Care Fund 3,285,758 sh (unchged)
Joel Greenblatt Sold Out
Pioneer Investments 135,182 sh (-1.47%)
Jim Simons 404,610 sh (-36.09%)
» More
Q4 2013

BRKR Guru Trades in Q4 2013

NWQ Managers 1,136,005 sh (+415.25%)
Murray Stahl 26,618 sh (+61.03%)
Jim Simons 534,010 sh (+31.98%)
Pioneer Investments 177,836 sh (+31.55%)
Vanguard Health Care Fund 3,285,758 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
» More
Q1 2014

BRKR Guru Trades in Q1 2014

Joel Greenblatt 94,974 sh (New)
Steven Cohen 17,278 sh (New)
Pioneer Investments 287,632 sh (+61.74%)
Murray Stahl 33,965 sh (+27.6%)
NWQ Managers 1,207,030 sh (+6.25%)
Vanguard Health Care Fund 3,285,758 sh (unchged)
Jim Simons 450,210 sh (-15.69%)
» More
» Details

Insider Trades

Latest Guru Trades with BRKR

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 New Buy0.03%$19.07 - $24.25 $ 23.8810%94974
Joel Greenblatt 2013-09-30 Sold Out 0.02%$15.91 - $20.99 $ 23.8825%0
Vanguard Health Care Fund 2013-06-30 Add 307.28%0.14%$15.94 - $19.13 $ 23.8838%3285758
Vanguard Health Care Fund 2013-03-31 New Buy0.06%$15.238 - $19.1 $ 23.8837%806758
Joel Greenblatt 2012-12-31 Reduce -84.28%0.18%$11.77 - $15.54 $ 23.8873%38498
Joel Greenblatt 2012-09-30 New Buy0.21%$11.34 - $14.13 $ 23.8889%244897
Joel Greenblatt 2011-06-30 Sold Out 0.1%$17.36 - $21.44 $ 23.8824%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 47.80
BRKR's P/E(ttm) is ranked higher than
59% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 31.90 vs. BRKR: 47.80 )
BRKR' s 10-Year P/E(ttm) Range
Min: 7.15   Max: 107.17
Current: 47.8

7.15
107.17
P/B 4.70
BRKR's P/B is ranked lower than
63% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.65 vs. BRKR: 4.70 )
BRKR' s 10-Year P/B Range
Min: 1.32   Max: 8.89
Current: 4.7

1.32
8.89
P/S 2.16
BRKR's P/S is ranked lower than
54% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.00 vs. BRKR: 2.16 )
BRKR' s 10-Year P/S Range
Min: 0.5   Max: 2.55
Current: 2.16

0.5
2.55
PFCF 29.10
BRKR's PFCF is ranked higher than
72% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 83.39 vs. BRKR: 29.10 )
BRKR' s 10-Year PFCF Range
Min: 9.23   Max: 159.85
Current: 29.1

9.23
159.85
EV-to-EBIT 24.61
BRKR's EV-to-EBIT is ranked higher than
65% of the 2659 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 23.82 vs. BRKR: 24.61 )
BRKR' s 10-Year EV-to-EBIT Range
Min: 5.6   Max: 82
Current: 24.61

5.6
82
PEG 12.00
BRKR's PEG is ranked higher than
79% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. BRKR: 12.00 )
BRKR' s 10-Year PEG Range
Min: 0.48   Max: 12.1
Current: 12

0.48
12.1
Shiller P/E 44.60
BRKR's Shiller P/E is ranked higher than
85% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. BRKR: 44.60 )
BRKR' s 10-Year Shiller P/E Range
Min: 20.11   Max: 339.33
Current: 44.6

20.11
339.33
Current Ratio 2.20
BRKR's Current Ratio is ranked higher than
68% of the 2532 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.96 vs. BRKR: 2.20 )
BRKR' s 10-Year Current Ratio Range
Min: 1.26   Max: 4.99
Current: 2.2

1.26
4.99
Quick Ratio 1.28
BRKR's Quick Ratio is ranked higher than
56% of the 2532 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.44 vs. BRKR: 1.28 )
BRKR' s 10-Year Quick Ratio Range
Min: 0.43   Max: 3.95
Current: 1.28

0.43
3.95

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.20
BRKR's Price/Tangible Book is ranked lower than
59% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.98 vs. BRKR: 5.20 )
BRKR' s 10-Year Price/Tangible Book Range
Min: 1.35   Max: 20.45
Current: 5.2

1.35
20.45
Price/DCF (Projected) 2.30
BRKR's Price/DCF (Projected) is ranked higher than
85% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. BRKR: 2.30 )
BRKR' s 10-Year Price/DCF (Projected) Range
Min: 0.9   Max: 11.13
Current: 2.3

0.9
11.13
Price/Median PS Value 1.30
BRKR's Price/Median PS Value is ranked higher than
55% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.17 vs. BRKR: 1.30 )
BRKR' s 10-Year Price/Median PS Value Range
Min: 0.36   Max: 17.61
Current: 1.3

0.36
17.61
Price/Peter Lynch Fair Value 8.30
BRKR's Price/Peter Lynch Fair Value is ranked higher than
89% of the 2659 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. BRKR: 8.30 )
BRKR' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4   Max: 13.14
Current: 8.3

0.4
13.14
Price/Graham Number 3.30
BRKR's Price/Graham Number is ranked higher than
57% of the 2660 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.38 vs. BRKR: 3.30 )
BRKR' s 10-Year Price/Graham Number Range
Min: 1.07   Max: 17.07
Current: 3.3

1.07
17.07
Earnings Yield (Greenblatt) 4.00
BRKR's Earnings Yield (Greenblatt) is ranked higher than
51% of the 2169 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 6.40 vs. BRKR: 4.00 )
BRKR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.2   Max: 17.9
Current: 4

1.2
17.9
Forward Rate of Return (Yacktman) 7.33
BRKR's Forward Rate of Return (Yacktman) is ranked higher than
77% of the 1567 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.05 vs. BRKR: 7.33 )
BRKR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -9.4   Max: 53.6
Current: 7.33

-9.4
53.6

Business Description

Industry: Computer Hardware » Scientific & Technical Instruments
Compare:A, ROP, GRMN, HXGBY, TRMB » details
Traded in other countries:BKD.Germany
Bruker Corporation is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The Company's technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. It also manufacture and distribute a range of field analytical systems for chemical, biological, radiological and nuclear, or CBRN, detection as well as superconducting wire products and devices. The Company is organized into four operating segments: the Bruker BioSpin group, the Bruker CALID group, the Bruker MAT group, and Bruker Energy & Supercon Technologies division. The Bruker BioSpin group is in the business of designing, manufacturing and distributing enabling life science tools based on magnetic resonance technology. The Bruker CALID group combines the Bruker Daltonics, Bruker Chemical and Applied Markets (CAM), Bruker Detection and Bruker Optics divisions and is in the business of designing, manufacturing, and distributing mass spectrometry and chromatography instruments and solutions for life sciences, including proteomics, metabolomics, and clinical research applications. Bruker CALID also designs, manufactures, and distributes various analytical instruments for CBRNE detection and research, as well as analytical, research and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The Bruker MAT group combines the Bruker AXS, Bruker Nano Surfaces, Bruker Nano Analytics and Bruker Elemental divisions and is in the business of manufacturing and distributing advanced analytical X-ray technologies and spark-optical emission spectroscopy, atomic force microscopy and stylus and optical metrology instrumentation used in non-destructive molecular, materials and elemental analysis. The Bruker Energy & Supercon Technologies division is in the business of developing and producing low temperature superconductor and high temperature superconductor materials for use in advanced magnet technology and energy applications as well as linear accelerators, accelerator cavities, insertion devices, other accelerator components and specialty superconducting magnets for physics and energy research and a variety of other scientific applications. The Company's has a global life sciences and advanced and raw materials customer base. Its life science customer base is composed mainly of end-users and includes pharmaceutical, biotechnology, proteomics, molecular diagnostics, food/feed/agricultural, and fine chemical companies, as well as commercial labo
» More Articles for BRKR

Headlines

Articles On GuruFocus.com
comment on BRKR Mar 23 2013 
Weekly CEO Buys Highlight: NGL, BRKR, UTHR, KTOS, GBL Dec 24 2012 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 10,000 Shares Mar 17 2011 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 1,220 Shares Mar 03 2011 
Weekly CEO Buys Highlight: Deer Consumer Products, Dynex Capital, Bruker BioSciences Corp, American Mar 27 2010 
Weekly CEO Buys Highlight: Bruker BioSciences Corp, Dynex Capital Inc, American Dairy Inc, Pioneer D Mar 21 2010 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares Mar 18 2010 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares Mar 15 2010 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 3,570 Shares Dec 15 2009 
Weekly CEO Buy Highlights: Bruker BioSciences Corp, Cousins Properties Inc, FIFTH STREET FINANCE, La Sep 27 2009 

More From Our Partners
Healthstream (HSTM) in Focus: Stock Rises 15.7% - Tale of the Tape Jul 23 2014 - ZACKS

More From Other Websites
BRUKER CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities Jul 23 2014
Danaher Q2 Earnings, Guidance Disappoint Wall Street Jul 17 2014
Bruker Announces Date and Time of Second Quarter 2014 Earnings Release and Webcast Jul 17 2014
Bruker's Inspire Mapping System Fails to Inspire Share Prices Jul 14 2014
Bruker Introduces Inspire Nanoscale Chemical Mapping System Jul 10 2014
Bruker Introduces Inspire Nanoscale Chemical Mapping System Jul 10 2014
Bruker Corp. downgraded by ISI Group Jul 08 2014
Bruker's MALDI Biotyper Approved for Biochemical Testing in China Jun 27 2014
Bruker receives CFDA clearance for MALDI Biotyper Jun 25 2014
The Bruker MALDI Biotyper™ Receives Clearance as a Medical Device from the China Food and Drug... Jun 25 2014
The Bruker MALDI Biotyper™ Receives Clearance as a Medical Device from the China Food and Drug... Jun 25 2014
Will This Analyst Upgrade Help Bruker (BRKR) Stock Today? Jun 19 2014
Bruker upgraded to Outperform from Market Perform at Wells Fargo Jun 19 2014
World’s Highest Field 21 Tesla Magnet for FT-ICR Mass Spectrometry Installed at National High... Jun 16 2014
Bruker Announces Powerful New Mass Spectrometry Systems and Solutions for Life-Science Research,... Jun 16 2014
3 Health Services Stocks Dragging The Industry Down May 30 2014
Bruker has a conference call hosted by JPMorgan May 27 2014
BRUKER CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 20 2014
BRUKER CORP Financials May 16 2014
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Bruker... May 15 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide